Therefore, it seems that the gene upregulation or the drug-induced overactivation of the KATP channel subunits, specifically Sur2A and its accessory subunits Kir6.1 and/or Kir6.2, can be associated with cancers. This evidence concerns the gene KCNJ11 and cancer.